Position in NAUT
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$472,643
-$1,043,536 QoQ
Shares Held
252,751
-35.3% QoQ
Ownership
0.199%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#24
of 93 holders
Holding Since
Dec 2020
21 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in NAUT Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026GOLDMAN SACHS GROUP INC holds $13,040,376,854 across 359 Biotechnology names. NAUT ranks #290 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
2,481,761 | $1,232,765,138 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,163,191 | $725,296,113 | |
| 3 | ROIV |
Roivant Sciences Ltd.
|
18,556,458 | $656,713,046 | |
| 4 | TECH |
BIO-TECHNE Corp
|
7,343,324 | $518,805,838 | |
| 5 | RVMD |
Revolution Medicines, Inc.
|
2,133,101 | $399,487,154 | |
| 6 | MRNA |
Moderna, Inc.
|
4,671,950 | $327,176,656 | |
| 7 | TNGX |
Tango Therapeutics, Inc.
|
9,980,620 | $311,994,180 | |
| 8 | INCY |
Incyte Corp
|
2,305,782 | $261,383,446 |
All Filings in NAUT
Export CSV
21 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $472,643 | 252,751 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $1,516,179 | 390,768 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $580,002 | 297,437 | Shares | Defined | 2026-03-25 | |
| 2025-09-30 | $99,469 | 117,716 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $228,329 | 314,938 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $147,907 | 171,787 | Shares | Defined | 2025-06-27 | |
| 2024-12-31 | $328,766 | 195,695 | Shares | Defined | 2025-02-11 | |
| 2024-09-30 | $462,634 | 162,328 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $193,960 | 82,889 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $185,325 | 63,036 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $200,392 | 67,021 | Shares | Defined | 2024-05-14 | |
| 2023-09-30 | $254,967 | 80,686 | Shares | Defined | 2024-05-15 | |
| 2023-06-30 | $368,272 | 95,161 | Shares | Defined | 2024-05-14 | |
| 2023-03-31 | $254,188 | 91,765 | Shares | Defined | 2024-05-14 | |
| 2022-12-31 | $127,467 | 70,815 | Shares | Defined | 2024-05-14 | |
| 2022-09-30 | $158,082 | 74,567 | Shares | Defined | 2024-05-14 | |
| 2022-06-30 | $209,290 | 77,803 | Shares | Defined | 2024-05-14 | |
| 2022-03-31 | $406,067 | 93,564 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $298,761 | 57,676 | Shares | Defined | 2022-02-17 | |
| 2021-09-30 | $63,997 | 10,423 | Shares | Defined | 2022-01-20 | |
| 2020-12-31 ARYA | — | 122,500 | Shares | Defined | 2021-02-12 | |
| No filing history on record for this holder in this stock. | ||||||